David Davidson
CIK 1578696 · Chief Medical Officer · last filed 2021-04-07
David Davidson is a Chief Medical Officer who has filed 88 SEC Form 4 insider transactions across 1 company since 2013. The most recent filing shows the insider sold $1.3K of BLUE on Apr 7, 2021. Across all open-market trades the lifetime net is −$39.2M, making them a net seller over the disclosed history. 92 SEC filings were submitted jointly with bluebird bio, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLUE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
60 BINNEY STREET
CAMBRIDGE, MA 02142
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| bluebird bio, Inc. (BLUE) Delisted | Chief Medical Officer | 2,389 | $4.97 | $11.9K | -$39.22M | 88 | 2021-04-07 |
Recent Filings
88 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-07 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −42 | -$1.3K | EDGAR |
| 2021-03-04 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −42 | -$1.2K | EDGAR |
| 2021-02-18 | bluebird bio, Inc. (BLUE) Delisted | Mixed | +11,573 | -$19.7K | EDGAR |
| 2021-02-04 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −63 | -$2.9K | EDGAR |
| 2021-01-08 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −3,215 | -$144.8K | EDGAR |
| 2020-12-04 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −64 | -$3.0K | EDGAR |
| 2020-11-04 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −63 | -$3.3K | EDGAR |
| 2020-10-06 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −64 | -$3.4K | EDGAR |
| 2020-09-08 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −41 | -$2.4K | EDGAR |
| 2020-08-05 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −42 | -$2.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.